Drug profile · INN
gramicidin
NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
gramicidin (NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN) is a cell membrane inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — gramicidin
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
gramicidin (NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN) is a cell membrane inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Cell membrane inhibitor
Primary target: Cell membrane
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is gramicidin?
gramicidin (NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN) is a cell membrane inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for gramicidin?
NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN is a marketed brand name for gramicidin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gramicidin?
gramicidin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.